Article: Cannabis compound may halve seizures for patients with severe epilepsy

Cannabis compound may halve seizures for patients with severe epilepsy

http://flip.it/UjtIiI

Um, yeah.  

Ohio State University scientists have proven what those of us who have been using the herb medicinally have known for years: Cannabidiol, or CBD, is a powerful antiepileptic medicine.  The article mentions a few of the other conditions and illnesses that CBD is known to help.

And in the tradition of medications being used precisely because of their side effects (think belladonna [atropine] which dries up respiratory secretions), note that the only side effects to CBD mentioned are sedation and appetite loss.  Useful, those, in certain circumstances.

While this publication is great news for helping to refute idiot attorneys general who still think cannabis has no medical benefit, it’s also cause for caution: right now the biggest threat to unrestricted adult use is…Big Pharma!

Yes, Big Pharma knows good medicine when it smells the scent of Big Money.  And friends, cannabis is big money, no matter how you cut it.

Big Pharma would much rather see the money from cannabis medicine in its own pocket, and we all know that Big Pharma has lots of senators and other influential players in its own pockets.

One chilling example: Arizona’s 2016 ballot measure that would have legalized adult use was narrowly shot down, largely due to a fierce anti-cannabis campaign bankrolled by the drug giant Insys, which is quartered in Arizona.  Insys produces a large proportion of the synthetic opioid fentanyl that is produced in the U.S.  Fentanyl is used in anesthesia and various delivery systems for treating pain.  It’s also been the culprit in many of the recent opioid overdose deaths we hear so much about.

You may be thinking: oh, right, statistics show that in states with legal cannabis, opioid prescriptions decline by about one-third.  So of course an opioid manufacturer doesn’t want that!

It gets worse.

Seems that Insys was just on the point of rolling out its first synthetic cannabinoid, a THC analog that is pretty much redundant not only because there are already synthetic THC products on the market, but also because anyone with a medical marijuana card can get their THC straight from the source.  

But that’s “not good for business,” as Texas Senator Ted Cruz pointed out when I mentioned that rolling back clean air laws is not good for children.  So Insys spent half a million bucks a couple of weeks before the election on a rabid T.V. ad campaign, spreading fear among the uninformed, mouthing the old saws about how marijuana causes violence, crime, unemployment, blah blah blah, and it worked.

So on one hand, the more good science, the more knowledge, the less fear, the better the public can understand and accept cannabis as medicine.

On the other, the more science, the more Big Pharma sees opportunity, the more danger that our access to this amazing plant could be once again restricted, in its natural form, in favor of…pills.

Comments are closed.